Impact of Implementing the Modified A-DIVA Scale on Successful Access to a Venous Line on the First Attempt
DIVAPERF
1 other identifier
interventional
200
1 country
3
Brief Summary
Peripheral venous access (PVA), although commonly used, can be a difficult procedure for patients with precarious venous capital. The difficulty of insertion can lead to multiple attempts, with the consequences of pain, anxiety, delayed management and worsening of the potentially already precarious venous capital. One study assessed the risk of failure according to a score based on venous status criteria. This study first established a link between venous status criteria and the risk of failure. The criteria defined as determinants were used to establish a venous status score. The data were then repeated by analyzing the success rate as a function of the scale score. A clear link between score and risk of failure was established. It seems worthwhile to evaluate the impact of implementing this scale prior to the placement of a peripheral venous line. The hypothesis is that obtaining a score predictive of failure would modify the therapeutic attitude of the registered nurse. They would opt for techniques that would increase their chances of success. This in turn would lead to a reduction in unsuccessful attempts, which generate pain and anxiety for the patient. Preserving venous capital by increasing first-attempt success is both a health issue for the patient and a guarantee of quality of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2024
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2023
CompletedFirst Posted
Study publicly available on registry
October 2, 2023
CompletedStudy Start
First participant enrolled
February 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
April 4, 2025
April 1, 2025
4.8 years
September 25, 2023
April 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Success rate of peripheral venous vein placement
Success rate of peripheral venous vein insertion on the first attempt in the 2 groups (group in which VVP insertion will be performed by nurses not trained in the A-DIVA score and group in which VVP insertion will be performed after score assessment by nurses trained in the A-DIVA score) expressed by the number of attempts equal to 1.
1 year
Secondary Outcomes (5)
Total number of attempts
1 year
Number of visualization techniques, alternative devices and/or third-party assistance used
1 year
Pain score: Numerical Pain Scale
1 year
Number of years' experience of nurses since obtaining diploma in nursing
1 year
A-DIVA scale score
1 year
Study Arms (2)
Control arm
NO INTERVENTIONNurses will place a peripheral venous line on these patients without having been trained in the venous status score predictive of failure.
Experimental arm
EXPERIMENTALNurses will place a peripheral venous line on these patients after being trained in the venous status score predictive of failure.
Interventions
Nurses are trained in the A-DIVA scale and its predictive failure score. This score enables them to adapt their approach to peripheral venous line insertion.
Eligibility Criteria
You may qualify if:
- Male or female patient of legal age included in a care program requiring a VVP;
- Fluency in French
- Patient affiliated to a social security scheme;
- Written, signed and dated informed consent.
You may not qualify if:
- As the A-DIVA scale specifies a search for venous access to the upper limb, any patient without an upper limb or with a condition that contraindicates VVP placement in the upper limbs will be excluded;
- Patients treated as emergencies;
- Patients with a language barrier or known significant cognitive or psychiatric disorders;
- Patients under guardianship, curatorship, deprivation of liberty or legal protection;
- Pregnant or breast-feeding women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
CHU Gabriel Montpied
Clermont-Ferrand, 63000, France
Centre Jean PERRIN
Clermont-Ferrand, 63011, France
Hôpital de la Croix Rousse
Lyon, 69004, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lucie MADELAINE
Centre Jean Perrin
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2023
First Posted
October 2, 2023
Study Start
February 27, 2024
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
April 4, 2025
Record last verified: 2025-04